Compare TTMI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTMI | BIO |
|---|---|---|
| Founded | 1978 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 8.2B |
| IPO Year | 2000 | N/A |
| Metric | TTMI | BIO |
|---|---|---|
| Price | $73.70 | $317.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $73.25 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.2M | 164.7K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.88 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $2,782,990,000.00 | $2,557,500,000.00 |
| Revenue This Year | $20.48 | $1.77 |
| Revenue Next Year | $9.21 | $2.30 |
| P/E Ratio | $58.45 | ★ N/A |
| Revenue Growth | ★ 17.88 | N/A |
| 52 Week Low | $15.78 | $211.43 |
| 52 Week High | $75.00 | $373.69 |
| Indicator | TTMI | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.30 | 50.96 |
| Support Level | $64.21 | $311.81 |
| Resistance Level | $69.93 | $328.07 |
| Average True Range (ATR) | 4.57 | 10.25 |
| MACD | 0.50 | -0.18 |
| Stochastic Oscillator | 93.35 | 55.82 |
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.